Clinical Trial Update: Study About Efficacy and Safety to Treat Multi-System-Atrophy [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating efficacy and safety of minocycline for multi-system atrophy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multi-system Atrophy

Drugs mentioned

• Minocycline (minocycline)

Snippet

Sponsor: German Parkinson Study Group (GPS) | Conditions: Multi-System-Atrophy, Minocycline | Phase 3 | Status: COMPLETED